Cellenkos Wins FDA Clearance for CK0801 Phase 2 Trial
HOUSTON, TEXAS, April 27, 2026 Cellenkos Inc. has received U.S. Food and Drug Administration (FDA) clearance to initiate a...
clinical trial
Advertisement
Galaxy Therapeutics Submits PMA for SEAL Device FDA
MILPITAS, CALIFORNIA, April 27, 2026 Galaxy Therapeutics has announced the submission of the final module of its Premarket Approval...
Adagio Medical Reports Positive vCLAS Results for VT
LOS ANGELES, April 2026 Adagio Medical announced positive pivotal clinical results for its vCLAS® Ventricular Ablation System, highlighting a...
Ascletis Advances ASC30 Phase II Trial in Diabetes
Hong Kong | April 27, 2026 Ascletis Pharma Inc. has announced the successful completion of enrollment in its U.S....
Compass Therapeutics Nears Key Data for Tovecimig in BTC
Boston, Massachusetts | April 24, 2026 Compass Therapeutics has announced it will present topline secondary endpoint data from its...
Advertisements
Johnson & Johnson IMAAVY Delivers 2-Year gMG Control
HORSHAM, Pa., April 22, 2026 Johnson & Johnson has reported compelling long-term Phase 3 data demonstrating that IMAAVY® (nipocalimab-aahu)...
Mabwell 9MW2821 Advances to Phase III in TNBC Trial
SHANGHAI, April 23, 2026 Mabwell has announced the initiation of a Phase III clinical trial for its proprietary Nectin-4-targeting...
Kyowa Kirin, Kura Oncology Launch Ziftomenib AML Trial
TOKYO & SAN DIEGO, April 24, 2026 Kyowa Kirin and Kura Oncology have announced a major clinical milestone with...
Envoy Medical Acclaim Implant Trial Hits Key Milestone
WHITE BEAR LAKE, Minn., April 22, 2026 Envoy Medical, Inc. announced a major milestone in its pivotal clinical trial...
Akeso Cadonilimab Combo Shows Strong Survival in Pancreatic Cancer
Hong Kong, April 20, 2026 In a significant breakthrough in oncology immunotherapy, Akeso, Inc. has announced promising Phase II...
Advertisement
